Lice Treatment Market Application, Growth Factors, Development and Forecast 2027.
The Global Lice
Treatment Market is expected to grow at an approximate CAGR of 6.5% during
forecast period, 2018–2023.Lice are parasites striving on human blood. They can
be found on head or pubic areas. From the past few years, rising prevalence of
head lice provided developmental backgrounds for the market. Factors such as
growing children population and increasing disposable income are driving the
market. However, lack of awareness followed by low per capita healthcare
expenditure in the developing and low-income countries is estimated to
restraint the market growth, during the forecast period.
Segmentation:
The global lice treatment market is segmented based on type,
treatment, end user, and region Based on type, the market is segmented into
pediculosis capitis, pediculosis corporis, and pediculosis pubis. On the basis
of treatment, the market is divided into two, i.e., OTC (over the counter)
products and prescription medications. The OTC medication segment is bifurcated
into permethrin, pyrethrin, and others.
The prescription segment is sub-segmented into ivermectin, spinosad,
malathion, and others. By distribution channel, the market is segmented into
hospitals & clinics, retail pharmacies, and online platform. On the basis
of region, the market is segmented into the Americas, Europe, Asia Pacific and
the Middle East & Africa.
Request
Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7134
Regional Analysis:
The Americas leads the global lice treatment market. This
can be attributed due to growing child population and presence of major market
players within the region. Moreover, the presence of developed economies like
U.S. and Canada within the region boost the market growth. In 2017, followed by
the Americas, Europe stood second in the global market owing to the presence of
a well-developed healthcare infrastructure, increasing awareness and high
healthcare expenditure. Asia Pacific was estimated to be the fastest growing
region in 2017. This can be attributed due to the high contamination rate,
increasing household income and growing penetration of the market players
within the region. Moreover, rapidly growing pharmaceutical sector within the
region boosts the market to grow. On the other hand, the Middle East and Africa
held the least share in the global lice treatment market. This can be
attributed due to the presence of poor economies, stringent government policies
and low per capita income, especially within the African region. A majority of
the of the market share within the Middle East & Africa is estimated to be
held by the Middle East due to increasing government funding for healthcare,
improving healthcare facilities and presence of developed economies like United
Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.
Key Players:
Some of the key players in the global lice treatment market
are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow
AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson
& Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro
Pharmaceuticals, Topaz Pharmaceuticals Inc., and others
Browse Detailed TOC
with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/lice-treatment-market-7134
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment